Systemic lupus erythematosus and pregnancy;Systemisk lupus erythematosus og svangerskap

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 6, 2007, Pages 725-729

  Skomsvoll, Johan Fredrik ^a,b   Aasarød, Knut ^a,b   Salvesen, Kjell Å ^a,b   Hoff, Mari ^a,b   Wallenius, Marianne ^a,b   Rødevand, Erik ^a   Koksvik, Hege Suorza Svean ^a   Gilboe, Inge Margrethe ^c   Nossent, Hans C ^d  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Rikshospitalet ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY;

FEMALE; FETUS MONITORING; HUMAN; IMMUNOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; NEWBORN; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; REVIEW; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; FETAL MONITORING; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS;

EID: 33947238768     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 751.
2. Nossent HC. Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol 2001; 28: 539-46.
3. Cooper GS, Dooley MA, Treadwell EL et al. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. Arthritis Rheum 2002; 46: 1830-9.
4. Skomsvoll JF, Ostensen M, Irgens LM et al. Perinatal outcome in pregnancies of women with connective tissue disease and inflammatory rheumatic disease in Norway. Scand J Rheumatol 1999; 28: 352-6.
5. Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum Dis Clin North Am 1997; 23: 1-13.
6. Khamashta MA, Ruiz-Irastorza G, Hughes GR. Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 1997; 23: 15-30.
7. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991; 34: 1538-45.
8. Ruiz-Irastorza G, Lima F, Alves J et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 1996; 35: 133-8.
9. Oviasu E, Hicks J, Cameron JS. The outcome of pregnancy in women with lupus nephritis. Lupus 1991; 1: 19-25.
10. Hou SH. Pregnancy in women with lupus nephritis. I: Lewis EJ. Lupus Nephritis.. Oxford: Oxford Clinical Nephrology series, 1999: 262-79.
11. Hayslett JP, Lynn RI. Effect of pregnancy in patients with lupus nephropathy. Kidney Int 1980; 18: 207-20.
12. Julkunen H, Kaaja R, Palosuo T et al. Pregnancy in lupus nephropathy. Acta Obstet Gynecol Scand 1993; 72: 258-63.
13. Carmona F, Font J, Moga I et al. Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol 2005; 53: 182-8.
14. Kincaid-Smith P, Fairley KF, Kloss M. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med 1988; 68: 795-815.
15. Bazzan M, Donvito V. Low-molecular-weight heparin during pregnancy. Thromb Res 2001; 101: 175-86.
16. Brandt JT, Triplett DA, Alving B et al. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
17. McMillan E, Martin WL, Waugh J et al. Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome. Lupus 2002; 11: 392-8.
18. Mintz G, Niz J, Gutierrez G et al. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 1986; 13: 732-9.
19. Nossent HC, Swaak TJ. Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J Rheumatol 1990; 17: 771-6.
20. Petri M, Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol 1993; 20: 650-6.
21. Moroni G, Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J Nephrol 2003; 16: 161-7.
22. Moroni G, Quaglini S, Banfi G et al. Pregnancy in lupus nephritis. Am J Kidney Dis 2002; 40: 713-20.
23. Jungers P, Dougados M, Pelissier C et al. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med 1982; 142: 771-6.
24. Rahman P, Gladman DD, Urowitz MB. Clinical predictors of fetal outcome in systemic lupus erythematosus. J Rheumatol 1998; 25: 1526-30.
25. Cortes-Hernandez J, Ordi-Ros J, Paredes F et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology 2002; 41: 643-50.
26. Shah NM, Khamashta MA, Atsumi T et al. Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus 1998; 7: 3-6.
27. Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-27.
28. Loizou S, Byron MA, Englert HJ et al. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Q J Med 1988; 68: 525-31.
29. Ninomiya C, Taniguchi O, Kato T et al. Distribution and clinical significance of lupus anticoagulant and anticardiolipin antibody in 349 patients with systemic lupus erythematosus. Intern Med 1992; 31: 194-9.
30. Meroni PL, di SN, Testoni C et al. Antiphospholipid antibodies as cause of pregnancy loss. Lupus 2004; 13: 649-52.
31. Ramsey-Goldman R, Kutzer JE, Kuller LH et al. Previous pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with systemic lupus erythematosus. Am J Reprod Immunol 1992; 28: 195-8.
32. Skjærven R, Gjessing HK, Bakketeig LS et al. Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand 2000; 79: 435-9.
33. Ogishima D, Matsumoto T, Nakamura Y et al. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies. Pathol Int 2000; 50: 224-9.
34. Magid MS, Kaplan C, Sammaritano LR et al. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 1998; 179: 226-34.
35. Petri M. Prospective study of systemic lupus erythematosus pregnancies. Lupus 2004; 13: 688-9.
36. Hayslett JP. The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome. Am J Reprod Immunol 1992; 28: 199-204.
37. Yasmeen S, Wilkins EE, Field NT et al. Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med 2001; 10: 91-6.
38. Lima F, Buchanan NM, Khamashta MA et al. Obstetric outcome in systemic lupus erythematosus. Semin Arthritis Rheum 1995; 25: 184-92.
39. Lockshin MD. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989; 32: 665-70.
40. Burkett G. Lupus nephropathy and pregnancy. Clin Obstet Gynecol 1985; 28: 310-23.
41. Julkunen H. Renal lupus in pregnancy. Scand J Rheumatol 1998; 107 (suppl): 80-3.
42. Branch DW. Pregnancy in patients with rheumatic diseases: obstetric management and monitoring. Lupus 2004; 13: 696-8.
43. Buyon JP, Clancy RM. Neonatal lupus: basic research and clinical perspectives. Rheum Dis Clin North Am 2005; 31: 299-313.
44. Brucato A, Frassi M, Franceschini F et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-5.
45. Julkunen H, Kaaja R, Siren MK et al. Immune-mediated congenital heart block (CHB): identifying and counseling patients at risk for having children with CHB. Semin Arthritis Rheum 1998; 28: 97-106.
46. Ostensen M. Disease specific problems related to drug therapy in pregnancy. Lupus 2004; 13: 746-50.
47. Armenti VT, Ahlswedw KM, Ahlswede BA et al. Variables affecting birthweight and graft survival in 197 pregnancy in cyclosporin treated renal transplant recipients. Transplantation 1995; 59: 476-79.
48. Costedoat-Chalumeau N, Amoura Z, Huong du LT et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmun Rev 2005; 4: 111-5.
49. Ruiz-Irastorza G, Khamashta MA, Gordon C et al. Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. Arthritis Rheum 2004; 51: 78-82.
50. Ruiz-Irastorza G, Khamashta MA. Evaluation of systemic lupus erythematosus activity during pregnancy. Lupus 2004; 13: 679-82.
51. Ostensen ME, Skomsvoll JF. Anti-inflammatory pharmacotherapy during pregnancy. Expert Opin Pharmacother 2004; 5: 571-80.
52. Cunningham FG, Lindheimer MD. Hypertension in pregnancy. N Engl J Med 1992; 326: 927-32.
53. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio Ipertensione in Gravidanza. Br J Obstet Gynaecol 1998; 105: 718-22.
54. Ruiz-Irastorza G, Khamashta MA. Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Ann N Y Acad Sci 2005; 1051: 606-12.
55. Triolo G, Ferrante A, Accardo-Palumbo A et al. IVIG in APS pregnancy. Lupus 2004; 13: 731-5.
56. Saleeb S, Copel J, Friedman D et al. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999; 42: 2335-45.
57. Breur JM, Visser GH, Kruize AA et al. Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature. Ultrasound Obstet Gynecol 2004; 24: 467-72.
58. Jacobsen AF, Dahl GF, Henriksen T et al. Veileder i fødselshjelp. Kapittel 15. Tromboemboliske komplikasjoner. www.medisinstudent.no/asset/32196/ 1/32196_1.pdf (2.10.2006).
59. Skomsvoll JF, Ostensen M, Irgens LM et al. Pregnancy complications and delivery practice in women with connective tissue disease and inflammatory rheumatic disease in Norway. Acta Obstet Gynecol Scand 2000; 79: 490-5.
60. Skomsvoll JF, Baste V, Irgens LM et al. The recurrence risk of adverse outcome in the second pregnancy in women with rheumatic disease. Obstet Gynecol 2002; 100: 1196-202.
61. Skomsvoll JF, Salvesen KÅ, Steen R. Veileder i fødselshjelp. Kapittel 12. Inflammatorisk revmatisk sykdommer og kollagenoser. www.medisinstudent.no/asset/32196/1/32196_1.pdf (2.10.2006).